Clostridium difficile outbreak in Costa Rica: Control actions and associated factors

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 32, Issue 6, 2012, Pages 413-418

  Wong McClure, Roy A ^a   Guevara Rodríguez, Moraima ^a   Abarca Gómez, Leandra ^a   Solano Chinchilla, Antonio ^a   Marchena Picado, Margarita ^a   O'Shea, Michele ^b   Badilla Vargas, Xiomara ^a  

^a CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Costa Rica; Enterocolitis

Indexed keywords

BACTERIAL DISEASE; COHORT ANALYSIS; DISEASE SPREAD; DISEASE TRANSMISSION; HEALTH RISK; HOSPITAL SECTOR; INFECTIOUS DISEASE; PUBLIC HEALTH; SPATIOTEMPORAL ANALYSIS;

COSTA RICA;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 84874831844     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892012001400004     Document Type: Article

References (20)

1. Paredes-Sabja D, Bond C, Carman RJ, Setlow P, Sarker MR. Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficileassociated disease (CDAD). Microbiology. 2008;154(Pt 8):2241-50.
2. Kutty PK, Benoit SR, Woods CW, Sena AC, Naggie S, Frederick J, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol. 2008;29(3):197-202.
3. Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S, et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med. 2006;166(22):2518-24.
4. Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther. 2009;29(6):626-34.
5. Salgado CD, Mauldin PD, Fogle PJ, Bosso JA. Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures. Am J Infect Control. 2009;37(6):458-64.
6. Polgreen PM, Chen YY, Cavanaugh JE, Ward M, Coffman S, Hornick DB, et al. An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28(2):212-4.
7. Quesada-Gómez C, Rodríguez C, Gamboa- Coronado M del M, Rodríguez-Cavallini E, Du T, Mulvey MR, et al. Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol. 2010;48(2):669-70.
8. Borges SL, Pinheiro B do V, Pace FH de L, Chebli JMF. Diarréia nosocomial em unidade de terapia intensiva: incidência e fatores de risco. Arq Gastroenterol. 2008;45(2):117-23.
9. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.
10. Ahrens W, Pigeot I, eds. Handbook of epidemiology. New York: Springer; 2005.
11. Caja Costarricense de Seguro Social. Lineamientos para la vigilancia de Clostridium difficile en la red hospitalaria de la Caja Costarricense de Seguro Social. San José: Caja Costarricense de Seguro Social; 2009.
12. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficileassociated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173(9):1037-42.
13. Weiss K, Boisvert A, Chagnon M, Duchesne C, Habash S, Lepage Y, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009;30(2): 156-62.
14. Kallen AJ, Thompson A, Ristaino P, Chapman L, Nicholson A, Sim B-T, et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol. 2009;30(3):264-72.
15. Barbut F, Jones G, Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011;24(4):370-6.
16. Gould D. Prevention and control of Clostridium difficile infection. Nurs Older People. 2010;22(3):29-34; quiz 35.
17. Viswanathan V, Mallozzi M, Vedantam G. Clostridium difficile infection: an overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes. 2010;1(4):234-42.
18. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18(2):247-63.
19. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt). 2007;8(6):557-66.
20. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008;14(Suppl 5):2-20.